Get started
Author

Mwanasha Hamuza Merrill

Postdischarge thrombosis and hemorrhage in patients with COVID-19
2020 · Rushad Patell, Thomas Bogue, et al. · Blood · 247
PDF
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
2020 · Rushad Patell, Thomas Bogue, et al. · Journal of Thrombosis and Haemostasis · 62
PDF
Heparin induced thrombocytopenia antibodies in Covid‐19
2020 · Rushad Patell, Adeel M Khan, et al. · American Journal of Hematology · 54
PDF
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
2023 · David A. Qualls, Nicholas Lambert, et al. · Blood · 49
PDF
Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study
2022 · David Qualls, Michael J Buege, et al. · Blood · 20
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
2023 · Mwanasha H. Merrill, Parastoo B. Dahi, et al. · Blood · 15
PDF
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
2024 · Jessy Xinyi Han, Min Jung Koh, et al. · Blood Advances · 14
PDF
Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers
2023 · Emily Ayers, Viktoriya Zelikson, et al. · Blood · 11
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas
2025 · Josie G. Ford, Min Jung Koh, et al. · Blood Advances · 8
PDF
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers
2024 · Viktoriya Zelikson, Ashwath Gurumurthi, et al. · Haematologica · 7
PDF
Forecasting optimal treatments in relapsed/refractory mature T‐ and NK ‐cell lymphomas: A global PETAL Consortium study
2025 · Mark N. Sorial, Jessy Xinyi Han, et al. · British Journal of Haematology · 4
PDF
Detection of Maternal Malignancy after Abnormal Noninvasive Prenatal Testing (NIPT)
2023 · Mwanasha Hamuza Merrill, Sophie Cahill, et al. · Blood · 4
Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas
2024 · Josie G Ford, Sean M McCabe, et al. · Blood · 3
Access to Diagnosis through Liquid Biopsy (ADLiB): A Cell-Free DNA Assay to Diagnose Lymphoma and Differentiate from Other Causes of Enlarged Lymph Nodes
2024 · Katherine Antel, Mwanasha H. Merrill, et al. · Blood · 2
Detection of Maternal Malignancy After Abnormal Noninvasive Prenatal Testing: A Single-Center Case Series
2024 · Mwanasha H. Merrill, Sophie R. Cahill, et al. · JCO Precision Oncology · 2
Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B Cell Lymphoma
2023 · David A Qualls, Nicholas Lambert, et al. · Blood · 2
PDF
Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortium
2025 · Michael Randall, Wendy Swetzig Dhiman, et al. · Blood · 1
PDF
Outcomes of tafasitamab and lenalidomide in large B‐cell lymphoma based on prior CD19‐directed CAR T exposure
2025 · Mwanasha H. Merrill, Robert A. Redd, et al. · HemaSphere · 1
PDF
A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas
2025 · Mwanasha H. Merrill, Robert A. Redd, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms
2023 · Min Jung Koh, Leora Boussi, et al. · Blood · 1
PDF
Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era
2022 · Leora S Boussi, Min Jung Koh, et al. · Blood · 1
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
2022 · Min Jung Koh, Mwanasha H. Merrill, et al. · Blood Advances · 1
PDF
Abstract B198: Selinexor (KPT-330), a novel Selective Inhibitor of Nuclear Export (SINE) shows marked NF-kB inhibition and significant anticancer activity against Non-Small Cell Lung Cancer (NSCLC).
2013 · William Senapedis, Marsha Crochiere, et al. · Molecular Cancer Therapeutics · 1
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
2026 · Robert Stuver, Zachary R. Moore, et al. · Haematologica
PDF
Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis‐endemic setting
2026 · Katherine Antel, Nina Xiong, et al. · HemaSphere
Works count: 41
Citation count: 510
H-index: 8
I10-index: 8
Year
Topic
Type